[Edaily] C&R Research, AbClon, and GCCL signed an MOU to ‘Develop Analytical Methods for Biopharmaceuticals’
C&R Research, AbClon, and GCCL signed an MOU to ‘Develop Analytical Methods for Biopharmaceuticals’.
Moon-Tae Yoon, CEO of C&R Research, expressed, “By collaborating with partner companies that demonstrate expertise from the early stages of new drug development, even before clinical trials begin, we can ensure smoother clinical trial processes. We expect this MOU to contribute to global market entry.”
Through this MOU, the three companies will not only support AbClon’s therapeutic development efforts but also offer integrated and efficient services to domestic pharmaceutical companies and bioventures engaged in new drug development, aiming to achieve successful clinical trial outcomes.
Please check out further details by following the link below.
